CLINICAL_TRIALS
trial_result
· 2018-11-27
Clinical Trial Update: Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis [Phase 3]
Summary
Phase 3 trial update on rivaroxaban for symptomatic isolated distal deep vein thrombosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Walter Ageno | Conditions: Deep Vein Thrombosis | Phase 3 | Status: UNKNOWN